OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SGLT2 inhibition, circulating metabolites, and atrial fibrillation: a Mendelian randomization study
Jiang Li, Yuefeng Yu, Ying Sun, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 26
Jiang Li, Yuefeng Yu, Ying Sun, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample Mendelian randomization study
Wenqin Guo, Lingyue Zhao, Weichao Huang, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Wenqin Guo, Lingyue Zhao, Weichao Huang, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
SGLT1 and SGLT2 inhibition, circulating metabolites, and cerebral small vessel disease: a mediation Mendelian Randomization study
Yanchen Lv, Xin Cheng, Qiang Dong
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Yanchen Lv, Xin Cheng, Qiang Dong
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Association between triglyceride glucose index and adverse cardiovascular prognosis in patients with atrial fibrillation without diabetes: a retrospective cohort study
Aobo Gong, Ying Cao, Zexi Li, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Aobo Gong, Ying Cao, Zexi Li, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Sodium–glucose cotransporter 2 inhibitors and the cancer patient: from diabetes to cardioprotection and beyond
Massimiliano Camilli, Marcello Viscovo, Luca Maggio, et al.
Basic Research in Cardiology (2024)
Open Access | Times Cited: 7
Massimiliano Camilli, Marcello Viscovo, Luca Maggio, et al.
Basic Research in Cardiology (2024)
Open Access | Times Cited: 7
Effects of Heart Failure Therapies on Atrial Fibrillation: Biological and Clinical Perspectives
Alfredo Mauriello, Antonia Ascrizzi, Anna Selvaggia Roma, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 806-806
Open Access | Times Cited: 5
Alfredo Mauriello, Antonia Ascrizzi, Anna Selvaggia Roma, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 806-806
Open Access | Times Cited: 5
The potential anti-arrhythmic effect of SGLT2 inhibitors
Hong-Yi Duan, Héctor Barajas-Martínez, Charles Antzelevitch, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Hong-Yi Duan, Héctor Barajas-Martínez, Charles Antzelevitch, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Reno-protective Effects of Empagliflozin in High Fat Diet Induced Obesity-Related Glomerulopathy by Regulation of Gut-Kidney Axis
Lei Lei, Ting Zhu, Tian-Jiao Cui, et al.
AJP Cell Physiology (2024) Vol. 327, Iss. 4, pp. C994-C1011
Open Access | Times Cited: 5
Lei Lei, Ting Zhu, Tian-Jiao Cui, et al.
AJP Cell Physiology (2024) Vol. 327, Iss. 4, pp. C994-C1011
Open Access | Times Cited: 5
Pharmacological targets of SGLT2 inhibition on prostate cancer mediated by circulating metabolites: a drug-target Mendelian randomization study
Yilong Lin, Yue Zhang, Songsong Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Yilong Lin, Yue Zhang, Songsong Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Stroke in the Patient with Type 2 Diabetes
Terri Jerkins, David S.H. Bell
Endocrine Practice (2025)
Closed Access
Terri Jerkins, David S.H. Bell
Endocrine Practice (2025)
Closed Access
Implications of Heart Failure Treatment on Atrial Fibrillation Onset: A Retrospective Study
Loredana Suhov, Adrian Apostol, Larissa Dăniluc, et al.
Medicina (2025) Vol. 61, Iss. 3, pp. 414-414
Open Access
Loredana Suhov, Adrian Apostol, Larissa Dăniluc, et al.
Medicina (2025) Vol. 61, Iss. 3, pp. 414-414
Open Access
Sex Differences in Atrial Fibrillation: Evidence from Circulating Metabolites
Ningjing Qian, Junyan Jin, Ying Gao, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 170-170
Open Access
Ningjing Qian, Junyan Jin, Ying Gao, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 170-170
Open Access
Sodium‐Glucose Cotransporter‐2 Inhibitors and Diabetic‐Ketoacidosis in T2DM Patients: An Updated Meta‐Analysis and a Mendelian Randomization Analysis
Yufei Wang, Yuhan Qin, Jing Zhang, et al.
Clinical Pharmacology & Therapeutics (2025)
Closed Access
Yufei Wang, Yuhan Qin, Jing Zhang, et al.
Clinical Pharmacology & Therapeutics (2025)
Closed Access
Ketone Bodies in Renal Function and Diabetic Kidney Disease
Hamza Mechchate
The Journal of Nutritional Biochemistry (2025), pp. 109915-109915
Closed Access
Hamza Mechchate
The Journal of Nutritional Biochemistry (2025), pp. 109915-109915
Closed Access
SGLT2 inhibition, high-density lipoprotein, and kidney function: a mendelian randomization study
Zhijuan Wang, Jie Wei, Wenman Zhao, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Zhijuan Wang, Jie Wei, Wenman Zhao, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Immune cell signatures and inflammatory mediators: unraveling their genetic impact on chronic kidney disease through Mendelian randomization
Yongzheng Hu, Fengyun Hao, Qian An, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Yongzheng Hu, Fengyun Hao, Qian An, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
SGLT2 Inhibition, Circulating Proteins, and Insomnia: A Mendelian Randomization Study
Jinlan Luo, Ling Tu, Chenchen Zhou, et al.
Sleep Medicine (2024) Vol. 119, pp. 480-487
Closed Access | Times Cited: 2
Jinlan Luo, Ling Tu, Chenchen Zhou, et al.
Sleep Medicine (2024) Vol. 119, pp. 480-487
Closed Access | Times Cited: 2
Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis
Tianshi Mao, Jie Chen, Tong Su, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Tianshi Mao, Jie Chen, Tong Su, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Electro-metabolic coupling in atrial fibrillation: A deeper understanding of the metabolic driver
Xinghua Qin, Lingyan Jin, Haoyu Gong, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117536-117536
Closed Access | Times Cited: 2
Xinghua Qin, Lingyan Jin, Haoyu Gong, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117536-117536
Closed Access | Times Cited: 2
Understanding the heterogeneity and dysfunction of HDL in chronic kidney disease: insights from recent reviews
Zhen Xu, Shuo Yang, Liyan Cui
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Zhen Xu, Shuo Yang, Liyan Cui
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Association between household size and risk of incident dementia in the UK Biobank study
Chaohua Cong, Panlong Li, Yuan Qiao, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Chaohua Cong, Panlong Li, Yuan Qiao, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Causal inference in the field of arrhythmia: An introduction to mendelian randomization
Eva Lukas, Margot P. van de Weijer, Jacob Bergstedt, et al.
Heart Rhythm (2024)
Closed Access | Times Cited: 1
Eva Lukas, Margot P. van de Weijer, Jacob Bergstedt, et al.
Heart Rhythm (2024)
Closed Access | Times Cited: 1
Metabolomics in Atrial Fibrillation: Unlocking Novel Biomarkers and Pathways for Diagnosis, Prognosis, and Personalized Treatment
Justyna Rohun, Danuta Dudzik, Joanna Raczak-Gutknecht, et al.
Journal of Clinical Medicine (2024) Vol. 14, Iss. 1, pp. 34-34
Open Access | Times Cited: 1
Justyna Rohun, Danuta Dudzik, Joanna Raczak-Gutknecht, et al.
Journal of Clinical Medicine (2024) Vol. 14, Iss. 1, pp. 34-34
Open Access | Times Cited: 1
Fine mapping-based multi-omics analysis interprets the gut-lung axis function of SGLT2 inhibitors
Fengqin Yuan, Tianlong Zhang, Sixiang Jia, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Fengqin Yuan, Tianlong Zhang, Sixiang Jia, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Therapeutic Targets of Antidiabetic Drugs and Kidney Stones: a Druggable Mendelian Randomization study and Experimental Study in Rats
Maolan Wu, Cheng He, Yu Hao, et al.
European Journal of Pharmacology (2024) Vol. 987, pp. 177197-177197
Closed Access
Maolan Wu, Cheng He, Yu Hao, et al.
European Journal of Pharmacology (2024) Vol. 987, pp. 177197-177197
Closed Access
White Matter Imaging Phenotypes Mediate the Negative Causality of Mitochondrial DNA Copy Number on Sleep Apnea: A Bidirectional Mendelian Randomization Study and Mediation Analysis
Qiaohui Ying, M Y Wang, Zichen Zhao, et al.
Nature and Science of Sleep (2024) Vol. Volume 16, pp. 2045-2061
Open Access
Qiaohui Ying, M Y Wang, Zichen Zhao, et al.
Nature and Science of Sleep (2024) Vol. Volume 16, pp. 2045-2061
Open Access
